Literature DB >> 31955444

A DNA damage multiscale model for NTCP in proton and hadron therapy.

Ramin Abolfath1, Chris Peeler1, Dragan Mirkovic1, Radhe Mohan1, David Grosshans1.   

Abstract

PURPOSE: To develop a first principle and multiscale model for normal tissue complication probability (NTCP) as a function of dose and LET for proton and in general for particle therapy with a goal of incorporating nanoscale radio-chemical to macroscale cell biological pathways, spanning from initial DNA damage to tissue late effects.
METHODS: The method is a combination of analytical and multiscale computational steps including (a) derivation of functional dependencies of NTCP on DNA-driven cell lethality in nanometer and mapping to dose and LET in millimeter, and (b) three-dimensional-surface fitting to Monte Carlo data set generated based on postradiation image change and gathered for a cohort of 14 pediatric patients treated by scanning beam of protons for ependymoma. We categorize voxel-based dose and LET associated with development of necrosis in NTCP. RESULT: Our model fits well the clinical data, generated for postradiation tissue toxicity and necrosis. The fitting procedure results in extraction of in vivo radio-biological α-β indices and their numerical values. DISCUSSION AND
CONCLUSION: The NTCP model, explored in this work, allows to correlate the tissue toxicities to DNA initial damage, cell lethality and the properties and qualities of radiation, dose, and LET.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  hadron therapy; machine learning; proton therapy; radio-biology; tissue toxicity

Mesh:

Year:  2020        PMID: 31955444     DOI: 10.1002/mp.14034

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  1 in total

1.  NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance.

Authors:  Meng-Yu Zhang; Ming Luo; Kai He; Xian-Ming Xia; Jie-Ping Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.